Company Reports

Recent Updates

All Reports

Stock Analyst Note

Wide-moat Coca-Cola delivered strong 2024 results, including increases of 12% and 7%, respectively, in organic sales and comparable EPS. Notably, global unit case volume expanded 1% for the year despite consumer pullback and geopolitical uncertainties. This resilient performance reaffirmed our investment thesis for Coke that is underpinned by its total beverage portfolio approach, steadfast commitment to product innovations and brand investments, and strong in-market execution. For 2025, we think management's outlook for organic sales growth of 5%-6% looks achievable on a balanced blend of volume and price increases, but we plan to trim our adjusted EPS estimate, before the earnings call, of $3.04 by a low-single-digit percentage to incorporate higher foreign currency headwinds. We don't plan any material changes to our $64 fair value estimate, and we view shares as fully valued.
Stock Analyst Note

Despite headwinds from consumer belt-tightening and geopolitical uncertainties, wide-moat Coca Cola delivered solid third-quarter results, including 9% and 5% growth in organic sales and comparable earnings per share, respectively. The resilient performance reaffirmed our constructive view on Coke’s long-term growth outlook underpinned by its total beverage portfolio strategy and unwavering commitment to product innovation and brand investment. We plan to maintain our 2024 sales and adjusted EPS forecasts of $46 billion and $2.86, respectively, which align with management's outlook, and our 10-year forecasts for mid-single-digit annual sales growth and low 30s operating margins. We maintain our $64 fair value estimate, and shares look fully valued.

Sponsor Center